3 results
Approved WMOSuspended
To determine the performance (safety and effectiveness) of miniaturo*-I for the treatment of urinary urge incontinence.
Approved WMORecruiting
Improves the alpha blocker Silodosin the bladder emptying in patients with MS? Improves the alpha blocker Silodosin the quality of life of patients with MS?
Not approvedWill not start
The primary objective of the PASSENGER study is to investigate any relationship between changes in SonR1 augmentation and a change in patients* exercise capacity as assessed by the 6 Minute Walk Test.